FDC Limited has informed the Exchange regarding a press release dated August 07, 2025, titled "Press Release on Q1 - FY 2025-26 Results".
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
FDC Limited reported a stable but mixed performance for Q1FY26, with consolidated operating revenue of ₹648 crore, up 1.6% YoY from ₹638 crore. PAT rose 1.9% YoY to ₹121 crore (EPS ₹7.45), but EBITDA declined 4.3% to ₹140 crore with margins compressing to 21.6% from 23.0%, hurt by a 271% surge in R&D spending (₹8.5 cr) and higher employee costs. The India formulations business (90% of revenue) grew 5.6% YoY to ₹579 cr, outperforming IPM growth of 8.0% as per IQVIA, while export formulations fell 33.8% YoY and emerging markets dropped 39% due to supply challenges. The US business showed recovery signs with FDA clarification on impurity standards received, and brand Electral crossed the ₹600 crore milestone, moving up to 14th rank in IPM.
Marginal revenue growth with margin compression may temper near-term sentiment, but strong India franchise performance, US business recovery, and a healthy order pipeline suggest a positive medium-term outlook for shareholders.